Yentl Lambrechts
Overview
Explore the profile of Yentl Lambrechts including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatse S, Lambrechts Y, Antoranz Martinez A, De Schepper M, Geukens T, Vos H, et al.
J Pathol
. 2024 Sep;
264(3):344-356.
PMID: 39344093
The impact of aging on the immune landscape of luminal breast cancer (Lum-BC) is poorly characterized. Understanding the age-related dynamics of immune editing in Lum-BC is anticipated to improve the...
2.
Wu Q, Hatse S, Kenis C, Fernandez-Garcia J, Altea-Manzano P, Billen J, et al.
Breast Cancer Res Treat
. 2024 Mar;
205(3):555-565.
PMID: 38472594
Purpose: Recent evidence suggests that age-accumulated methylmalonic acid (MMA) promotes breast cancer progression in mice. This study aims to investigate the association between baseline serum MMA concentrations in patients with...
3.
Lambrechts Y, Garg A, Floris G, Punie K, Neven P, Nevelsteen I, et al.
Genes Immun
. 2023 Sep;
24(5):270-279.
PMID: 37759086
There is an urgent need for new and better biomarker modalities to estimate the risk of recurrence within the luminal-like breast cancer (BC) population. Molecular diagnostic tests used in the...
4.
Lambrechts Y, Hatse S, Richard F, Boeckx B, Floris G, Desmedt C, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686617
The molecular mechanisms underlying the de novo metastasis of luminal breast cancer (dnMBC) remain largely unknown. Newly diagnosed dnMBC patients (grade 2/3, ER+, PR+/-, HER2-), with available core needle biopsy...
5.
Wu Q, Hatse S, Kenis C, Fernandez-Garcia J, Altea-Manzano P, Billen J, et al.
Geroscience
. 2023 Aug;
46(2):1489-1498.
PMID: 37632634
Methylmalonic acid (MMA), a by-product of propionate metabolism, is known to increase with age. This study investigates the potential of serum MMA concentrations as a biomarker for age-related clinical frailty...
6.
Altea-Manzano P, Doglioni G, Liu Y, Cuadros A, Nolan E, Fernandez-Garcia J, et al.
Nat Cancer
. 2023 Feb;
4(3):344-364.
PMID: 36732635
Metabolic rewiring is often considered an adaptive pressure limiting metastasis formation; however, some nutrients available at distant organs may inherently promote metastatic growth. We find that the lung and liver...
7.
Haase K, Sattar S, Pilleron S, Lambrechts Y, Hannan M, Navarrete E, et al.
J Geriatr Oncol
. 2022 Oct;
14(1):101385.
PMID: 36244925
Introduction: Ageism towards older adults with cancer may impact treatment decisions, healthcare interactions, and shape health/psychosocial outcomes. The purpose of this review is twofold: (1) To synthesize the literature on...
8.
Van Herck Y, Feyaerts A, Alibhai S, Papamichael D, Decoster L, Lambrechts Y, et al.
Lancet Healthy Longev
. 2022 Sep;
2(10):e663-e677.
PMID: 36098020
Roughly 50% of cancer cases occur in people aged 65 years or older. Older people are often diagnosed at a later stage and might receive less (intensive) treatment, which might...